SPY345.78+1.17 0.34%
DIA283.34-0.31 -0.11%
IXIC11,548.28+42.28 0.37%

RBC Capital Initiates Coverage On Metacrine with Outperform Rating, Announces Price Target of $25

RBC Capital analyst Brian Abrahams initiates coverage on Metacrine (NASDAQ:MTCR) with a Outperform rating and announces Price Target of $25.

· 10/12/2020 05:33
RBC Capital analyst Brian Abrahams initiates coverage on Metacrine (NASDAQ:MTCR) with a Outperform rating and announces Price Target of $25.